New York, NY, August 25, 2009-EbitdaEXTRA reports that negative EBITDA for DOR BioPharma, Inc. (OTC:DORB) for its twelve months ended June 30, 2009 was $(4,490,130), a 10.1% improvement over the year ... read full story
The markets opened higher as debt fears eased on speculation that the European Union might bailout Greece. The rising euro and weakening dollar are also lifting stocks in early trading. The Dow is posting early triple-digit gains and has moved above ... read full story
N/A 
